Christopher Davis - Davis Selected Advisers
Holding/activity history for Standard Biotools Inc (LAB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2016 Q2 | 0 | 0.00 | Sell 100.00% | 0.91 | SEC | ||
| 2016 Q1 | 1,701,662 | 0.91 | Reduce 4.34% | 0.04 | $117.13 | $199,316,000 | SEC |
| 2015 Q4 | 1,778,955 | 0.96 | Reduce 12.64% | 0.12 | $123.64 | $219,950,000 | SEC |
| 2015 Q3 | 2,036,449 | 0.96 | Reduce 51.69% | 0.97 | $108.47 | $220,894,000 | SEC |
| 2015 Q2 | 4,215,809 | 1.87 | Reduce 5.12% | 0.10 | $121.22 | $511,040,000 | SEC |
| 2015 Q1 | 4,443,459 | 2.00 | Reduce 25.05% | 0.54 | $126.09 | $560,276,000 | SEC |
| 2014 Q4 | 5,928,873 | 2.16 | Reduce 1.02% | 0.02 | $107.90 | $639,725,000 | SEC |
| 2014 Q3 | 5,989,780 | 1.98 | Reduce 11.23% | 0.24 | $101.76 | $609,534,000 | SEC |
| 2014 Q2 | 6,747,256 | 2.14 | Reduce 29.99% | 0.81 | $102.39 | $690,874,000 | SEC |
| 2014 Q1 | 9,638,047 | 2.71 | Add 0.80% | 0.02 | $98.21 | $946,553,000 | SEC |
| 2013 Q4 | 9,561,830 | 2.18 | Add 21.11% | 0.38 | $91.37 | $873,664,000 | SEC |
| 2013 Q3 | 7,894,873 | 2.08 | Add 34.20% | 0.53 | $99.14 | $782,698,000 | SEC |
| 2013 Q2 | 5,883,020 | 1.53 | Buy | 1.53 | $100.10 | $588,890,000 | SEC |
| 2010 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2010 Q3 | 14,250 | <0.01 | Reduce 1.52% | $78.46 | $1,118,000 | SEC | |
| 2010 Q2 | 14,470 | <0.01 | Reduce 99.62% | $75.33 | $1,090,000 | SEC | |
| 2010 Q1 | 3,828,553 | 0.00 | Add 0.85% | $75.71 | $289,860,000 | SEC | |
| 2009 Q4 | 3,796,412 | 0.71 | Add 9.78% | 0.06 | $74.84 | $284,123,000 | SEC |
| 2009 Q3 | 3,458,139 | 0.58 | Add 78.38% | 0.25 | $65.70 | $227,200,000 | SEC |
| 2009 Q2 | 1,938,667 | 0.33 | Add 0.59% | <0.01 | $67.79 | $131,422,000 | SEC |
| 2009 Q1 | 1,927,355 | 0.39 | Buy | 0.39 | $58.49 | $112,731,000 | SEC |